Skip to main content
SpringerLink
Log in

Antiretrovirals

Drug resistance leading to virologic failure: 7 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Chehadeh W, et al. Virologic failure after 48 weeks of raltegravir-based regimen in low HIV-1 incidence setting. Antiviral Chemistry and Chemotherapy 28: 2020. Available from: URL: http://doi.org/10.1177/2040206620927908

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Antiretrovirals. Reactions Weekly 1810, 39 (2020). https://doi.org/10.1007/s40278-020-80059-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-80059-3

Search

Navigation